Abstract
Dermal fibrosis, loss of cutaneous appendages, and loss of subcutaneous fat are the main manifestations of chronic graft-versus-host disease (cGVHD) in mice. Mast cells (MC) may have a role in cGVHD. To investigate this point we have evaluated the effect of a MC stabilizer (nedocromil sodium) and a MC activator (compound 48/80) on skin manifestations in a murine model of cGVHD (B10.D2 → BALB/c). Mice were treated with nedocromil sodium (5 mg/day) or compound 48/80 (10 μ g/day) from day −3 until day 15. Nedocromil ameliorated the skin features of cGVHD while compound 48/80 caused skin changes reminiscent of mild cGVHD in control mice. In addition nedocromil normalized peritoneal MC numbers and skin MC numbers and their activation state in the cGVHD mice. On the other hand compound 48/80 caused a complete disappearance of toluidine blue stainable peritoneal MC from cGVHD and control mice and decreased skin MC in controls. In summary, MC activation may play a negative role in the skin changes seen in cGVHD while MC stabilization ameliorates the skin manifestations of cGVHD and therefore may have a therapeutic benefit.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levi-Schaffer, F., Goldenhersh, M., Segal, V. et al. Nedocromil sodium ameliorates skin manifestations in a murine model of chronic graft-versus-host disease. Bone Marrow Transplant 19, 823–828 (1997). https://doi.org/10.1038/sj.bmt.1700734
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700734
Keywords
This article is cited by
-
Mast Cells and Immunological Skin Diseases
Clinical Reviews in Allergy & Immunology (2007)
-
Animal models for scleroderma: An update
Current Rheumatology Reports (2002)
-
Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
Bone Marrow Transplantation (2000)